Low Level Antibodies Against Alpha-Tropomyosin Are Associated With Increased Risk of Coronary Heart Disease
ConclusionG6PI, TPM1, and HnRNPDL were CHD natural autoantigens, and serum anti-TPM1 antibody could be used as a potential marker to predict the risk for CHD patients.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Autoimmune Disease | Cardiology | Cholesterol | Coronary Heart Disease | Drugs & Pharmacology | Heart | Heart Disease | Study